NCT00786253View on ClinicalTrials.gov

Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction

PHASE2CompletedINTERVENTIONAL

Enrollment

236

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

January 31, 2007

Conditions

Erectile Dysfunction

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

Vardenafil 10 mg on demand use

DRUG

Levitra (Vardenafil, BAY38-9456)

Vardenafil daily dosing 10 mg

Trial Locations (19)

12200

Berlin

19230

Hagenow

20251

Hamburg

20354

Hamburg

22299

Hamburg

30625

Hanover

35039

Marburg

40225

Düsseldorf

41515

Grevenbroich

48149

Münster

49076

Osnabrück

51375

Leverkusen

72076

Tübingen

81925

München

92637

Weiden

93053

Regensburg

04249

Leipzig

01662

Meißen

06097

Halle

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT00786253 - Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction | Biotech Hunter | Biotech Hunter